Streetbeat News

BTSG

BrightSpring Health Services Inc

Open

19.42

Mkt cap

3.2B

Volume

1.5M

High

19.42

P/E Ratio

-84.14

52-wk high

24.82

Low

18.44

Div yield

N/A

52-wk low

7.85

BrightSpring Health Services, Inc. (BTSG) saw a 12.6% increase in its stock price due to above-average trading volume. However, current earnings estimate revisions do not indicate continued strength.

Portfolio Pulse from

January 22, 2025 | 12:00 pm

BrightSpring Health Services Inc (BTSG) has agreed to sell its Community Living business, ResCare Community Living, to Sevita for $835 million in cash. This divestment allows BrightSpring to focus on its core activities.

Portfolio Pulse from

January 21, 2025 | 7:00 pm

BrightSpring Health Services, Inc. (NASDAQ: BTSG) has entered into an agreement to sell its Community Living business to Sevita for $835 million. The transaction is expected to close in 2025, pending regulatory approvals.

Portfolio Pulse from

January 20, 2025 | 11:45 pm

The Zacks Medical - Services industry is experiencing growth due to the expansion of the nursing care market and the adoption of digital healthcare. Companies like Doximity (DOCS), BrightSpring Health Services (BTSG), and Embecta Corp (EMBC) are expected to benefit significantly from these trends.

Portfolio Pulse from

January 03, 2025 | 9:45 am

BrightSpring Health Services, Inc. (BTSG) has been upgraded to a Zacks Rank #1 (Strong Buy), indicating positive earnings prospects and potential for stock price increase.

Portfolio Pulse from

January 02, 2025 | 6:30 pm

BrightSpring Health Services, Inc. (NASDAQ: BTSG) has successfully refinanced its $2.55 billion Term Loan B facility, which was due in February 2031, through its subsidiary Phoenix Guarantor Inc. The refinancing did not result in any additional indebtedness for the company.

Portfolio Pulse from

December 11, 2024 | 9:30 pm

BrightSpring Health Services announced that its specialty pharmacy partner, Onco360, has been chosen as the national pharmacy partner for several new drugs approved for treating advanced cancers and blood diseases.

Portfolio Pulse from

November 26, 2024 | 10:15 pm

BrightSpring Health Services announced that its subsidiary, CareMed, has been chosen as the national specialty pharmacy provider for Leqembi, an Alzheimer's treatment by Eisai. This partnership could enhance BrightSpring's market position.

Portfolio Pulse from

November 06, 2024 | 9:45 pm

BrightSpring Health shares are experiencing an increase in trading value following the company's announcement of an upward revision in its 2024 financial guidance.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 4:07 pm

BrightSpring Health has increased its FY2024 sales guidance from a range of $10.45 billion-$10.90 billion to $11.00 billion-$11.30 billion, surpassing the estimated $10.831 billion.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:08 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.